Christopher Colecchi

Christopher Colecchi is the Managing Director of Broadview Ventures. He leads the Broadview investment team and operations, and coordinates the activities of Broadview’s Strategic Advisory Board. Chris also oversees the investment activities of Longview Ventures.

Previously, Chris was the Vice President for Research Ventures and Licensing at Partners Healthcare (now Mass General Brigham) – an integrated health system founded by the Harvard-affiliated Brigham and Women’s Hospital and Massachusetts General Hospital. In this role, Chris led business development, technology transfer, and commercialization activities and managed efforts to establish strategic alliances with the life sciences industries. He also created the Partners Innovation Fund – a venture capital fund that makes investments in early stage companies emerging from Mass General Brigham hospitals.

Earlier in his career, Chris was the Director of Clinical Trials and Industrial Relations for the Massachusetts General Hospital and Director of Clinical Monitoring for a clinical research organization at which he oversaw the set-up and management of multi-center, industry-sponsored clinical trials at several hundred sites throughout the U.S. and Canada. Within these roles, Chris worked directly with most of the major international pharmaceutical and biotechnology companies as well as many in the device arena.

Chris currently serves on the boards of Ground Fluor Pharma (Chairman), EP Sciences, and Aggamin. He previously served on the boards of CardiAQ (Acquired by Edwards Life Sciences), miRagen (NSDQ: MGEN), Cardero (now Epirium Bio), GI Windows, and InfoBionic.

Outside of Broadview, Chris serves as an advisory board member for the University of Massachusetts School of Public Health and Health Sciences. He is a board member of the Massachusetts Association for Mental Health and the Institute for Cardiovascular Research and Science founded by the Royal Brompton and the Liverpool Heart and Chest Hospitals.

Chris holds a B.A. from the College of the Holy Cross and an M.P.H. from the University of Massachusetts School of Public Health at Amherst.